Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, sales continue to soar for Lilly and Novo Nordisk’s GLP-1s and Regeneron ...
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
The National Institutes of Health would slash funding for medical research doesn't make even cynical political sense. It's a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback